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Letter to the Editor
 
Dear Editor
 
I
 
NTERLEUKIN
 
 (IL)-4 
 
AND
 
 IL-8 
 
LEVELS
 
 
 
IN
 
 
 
SPUTUM
 
 
 
TAKEN
 
 
 
FROM
 
 
 
WHEEZY
 
 
 
INFANTS
 
 
 
AND
 
 
 
YOUNG
 
 
 
CHILDREN
 
 
 
IN
 
 
 
RELEVANT
 
 
 
TO
 
 
 
BACTERIAL
 
 
 
COLONIZATION
Respiratory viral infection is an established cause of
wheezing in childhood. However, whether bacterial
infection is related to exacerbations of childhood asthma
or is just an incidental finding remains uncertain. Reli-
able techniques for diagnosing bacterial respiratory
infection are currently unavailable. Recently, increased
local production of cytokines was shown to occur during
bacterial infections in adults with obstructive pulmonary
disease.
 
1,2
 
 Previously, we detected bacterial pathogens
in sputum samples taken from children with wheezing.
Thus, we speculated that bacteria may be involved in
asthma attacks in childhood.
 
3,4
 
 In the present study, we
obtained sputum specimens from infants and children
who had wheezing to examine the relationship between
bacterial colonization and the levels of several inflam-
matory markers, including interleukin (IL)-4 and IL-8, in
sputum.
We cultured bacterial pathogens in the sputum by
conventional methods.
 
3,4
 
 We also measured levels of
eosinophilic cationic protein (ECP), IL-4 and IL-8 in
sputum specimens. The specimens were confirmed to be
sputum by the presence of alveolar macrophages.
Sputum specimens with 
 
Streptococcus pneumoniae
 
 levels
of at least 10
 
5
 
 /mL or equivalent to at least 10-fold higher
than the levels of other bacterial species were defined as
being bacteria positive. Eosinophil cationic protein levels
were measured by Pharmacia ECP RIA (Pharmacia,
Upsalla, Sweden). Serum levels of specific IgE to mites,
egg white and milk were measured by ELISA with a Phar-
macia Immuno CAP-RAST system. Interleukin-4 and IL-8
levels in the sputum were measured by ELISA with a
Cytoscreen immunoassay human IL-4 US kit (Biosourse,
Camarillo, CA, USA) and a Pelikine Compact human
IL-8 ELISA kit (CLB, Amsterdam, The Netherlands). Res-
piratory syncytial virus (RSV) antigen in nasal secretion or
sputum was tested with a commercial kit (Abbott Test
Pack; Abbott Laboratories, Chicago, IL, USA).
The clinical characteristics, RSV antigen, RAST for
mites and milk, sputum ECP levels and sputum IL4 and
IL-8 levels in our subjects are given in Table 1. The RAST
for mite allergen was positive in four of 10 asthmatic
children. 
 
Streptococcus pneumoniae
 
 was identified in
sputum obtained from two children with mild recurrent
wheeze and three children with asthma. Respiratory syn-
cytial virus antigen was positive in six of 14 children.
Sputum ECP levels did not differ significantly between
subjects with 
 
S. pneumoniae
 
 infection and those without
 
S. pneumoniae
 
 infection. Sputum IL-4 levels were ele-
vated only in children with asthma, whereas sputum IL-8
levels were also elevated in children with wheezing.
Sputum IL-8 levels were significantly higher in the pres-
ence compared with the absence of bacterial infection in
children with recurrent wheezing and children with
asthma. The mean (
 
±
 
 SD) IL-8 level was significantly
higher in bacteria-positive specimens compared with
 
Table 1
 
Subjects
Diagnosis No. 
children
Age RSV ECP 
(ng/g)
RAST IL-4 
(pg/g)
IL-8 
(ng/g)Mite  Foods
First wheeze 1 1 month 1 190 0/1 0/1 0 36.4
Recurrent wheeze
 
Streptococcus pneumoniae
 
 
positive
2 5 months, 
6 months
2 39.0 
 
±
 
 14.1 0/2 1/2 0 29.7 
 
±
 
 24.3
 
Streptococcus pneumoniae
 
 
negative
1 1 year 0 373 0/1 0/1 0 6.8
Asthma
 
Streptococcus pneumoniae
 
 
positive
3 1 year 1/3 766.7 
 
±
 
 1105.4 0/3 0/3 4.0 
 
±
 
 2.4 97.2 
 
±
 
 98.8
 
Streptococcus pneumoniae
 
 
negative
7 9 months–
4 years
2/7 374.7 
 
±
 
 374.8 4/7 3/7 0.9 
 
±
 
 2.3 25.2 
 
±
 
 35.6
 
RSV, respiratory syncytial virus; ECP, eosinophil cationic protein; RAST, radioallergosorbent test; IL, interleukin.
 388 LETTER TO THE EDITOR
 
bacteria-negative specimens (70.2 
 
±
 
 80.0 
 
vs
 
 22.9 
 
±
 
33.6 ng/g, respectively; 
 
P
 
 < 0.05, Mann–Whitney
 
U
 
-test). The mean IL-4 level was significantly higher in
bacteria-positive specimens compared with bacteria-
negative specimens in children with asthma (4.0 
 
±
 
 2.4 
 
vs
 
0.9 
 
±
 
 2.3 pg/g, respectively; 
 
P
 
 < 0.05, Mann–Whitney
 
U
 
-test).
Bacterial infection has been considered an incidental
finding during asthma attacks. In contrast with respiratory
viral pathogens, direct evidence supporting a role for
bacterial infection in asthma attacks is lacking. Our
results showed that levels of both IL-8 and IL-4 were
increased in sputum with high bacterial counts. These
findings suggest a potential role for bacterial infection in
asthma attacks in children who have wheezing and are
consistent with results obtained in adults with chronic
obstructive disease.
 
1
 
 The inflammatory mediator IL-4, a
potent multifunctional cytokine in allergic disease, has
been reported to induce IgE isotype switching
 
5
 
 and to
stimulate mucus production.
 
6
 
 In general, Th2 cytokines
lead to mucin hypersecretion, an important cause of
airway obstruction. Soluble IL-4 receptor has been shown
to be effective for the management of asthma in adults.
 
7
 
Interleukin-4 and mast cells also have essential roles in
the early protective immune response against invading
pathogens. Human cord blood mast cells primed by IL-4
are activated and lead to pro-Th2 immune production in
the presence of bacterial antigens.
 
8
 
 Interleukin-4 induces
intercellular adhesion molecule expression in human
bronchial epithelial cells and potentiates tumor necrosis
factor-
 
α
 
 production.
 
9
 
 Sethi 
 
et al
 
.
 
1
 
 showed several lines
of evidence supporting a relationship between chronic
bacterial infection and allergic inflammation. In chronic
bacterial infection, macrophages skewed to Th2 mediate
immunity to respiratory pathogenic bacteria.
 
10
 
However, the relationsships among IL-4, IL-5 and
 
S. pneumoniae
 
 infection remain a matter of debate.
Unfortunately, we did not measure the levels of other
cytokines, such as IL-5 and IL-13, in the sputum. Perhaps,
bacteria contribute clinically to exacerbations of asthma.
This possibility deserves further attention because most
pathogenic bacteria can be controlled by antibiotics.
Currently, however, firm evidence linking 
 
S. pneumoniae
 
to exacerbations of asthma in children is lacking.
We  believe that recent evidence suggesting that
neutrophils are involved in the etiology of asthma
 
11
 
 justi-
fies further studies examining the relationship between
bacterial infection and respiratory disease in children with
wheezing.
 
R
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